

Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
BioCryst (BCRX) Surges 9.9%: Is This an Indication of Further Gains? | zacks.com • |
BioCryst Pharmaceuticals rallies on Quebec reimbursement for Orladeyo angioedema treatment | proactiveinvestors.com • |
BioCryst to Present at Upcoming Investor Conferences | globenewswire.com • |
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2023 Earnings Call Transcript | seekingalpha.com • |
BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates | zacks.com • |
BioCryst to Report Second Quarter 2023 Financial Results on August 3 | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-07 | 2023-09 | -0.25 | N/A | N/A | N/A |
2023-08-03 | 2023-06 | -0.25 | -0.24 | 0.01 | 4.00% |
2023-05-03 | 2023-03 | -0.3 | -0.28 | 0.02 | 6.67% |
2023-02-21 | 2022-12 | -0.19 | -0.38 | -0.19 | -100.00% |
2022-11-01 | 2022-09 | -0.32 | -0.23 | 0.09 | 28.13% |
2022-08-04 | 2022-06 | -0.36 | -0.32 | 0.04 | 11.11% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-13 | B of A Securities | Upgrade | Neutral | Buy |
2023-05-04 | RBC Capital | Upgrade | Sector Perform | |
2023-05-04 | Needham | Upgrade | Buy | |
2023-04-20 | Evercore ISI Group | Upgrade | Outperform | |
2023-04-20 | Needham | Upgrade | Buy | |
2023-03-14 | RBC Capital | Upgrade | Sector Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-06-12 | ABERCROMBIE GEORGE B | Director | 29.61K | Stock Award(Grant) |
2023-06-12 | ASELAGE STEPHEN J | Director | 63.34K | Stock Award(Grant) |
2023-06-12 | GALSON STEVEN K | Director | 29.61K | Stock Award(Grant) |
2023-06-12 | HEGGIE THERESA | Director | 49.11K | Stock Award(Grant) |
2023-06-13 | HUTSON NANCY J | Director | 81.82K | Sale |
2023-06-12 | LEE KENNETH B. | Director | 68.86K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Blackrock Inc. | 14.82M | 108.96M | 7.85% |
2023-03-30 | Vanguard Group, Inc. (The) | 14.83M | 108.97M | 7.85% |
2023-03-30 | Baker Brothers Advisors, LLC | 12.71M | 93.42M | 6.73% |
2023-03-30 | State Street Corporation | 11.39M | 83.71M | 6.03% |
2023-03-30 | Avoro Capital Advisors LLC | 10.42M | 76.59M | 5.52% |
2023-03-30 | Pictet Asset Management SA | 5.62M | 41.30M | 2.97% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-02-27 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 6.52M | 47.92M | 3.46% |
2022-12-30 | Vanguard Total Stock Market Index Fund | 5.65M | 41.54M | 3.00% |
2023-02-27 | iShares Russell 2000 ETF | 4.10M | 30.13M | 2.18% |
2023-02-27 | Fidelity Select Portfolios - Biotechnology | 2.69M | 19.79M | 1.43% |
2022-12-30 | Vanguard Extended Market Index Fund | 2.52M | 18.51M | 1.34% |
2022-12-30 | Vanguard Small-Cap Index Fund | 2.40M | 17.65M | 1.27% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |
-
-
$BCRX @Zee if I were in your shoes I’d be injecting that cognac. Let’s see what kind of ride we take tomorrow good luck
everyone
-
$BCRX 6 Shares give me a break
-
$BCRX @Gunnar the pictures you sent yesterday were beautiful. On another note I would be curious to know what the German population’s feelings are on the about face by the chancellor on the arms transfer to Ukraine. Thank you for your morning updates I’m always curious to what the pulse is on your side of the pond.
-
$BCRX The sanctions on drilling remain in place ,damn.
-
$BCRX Congratulations Martin. What color did you get?
-
$BCRX FYI Sanctions on domestic drilling may be lifted will he or won’t he
-
$BCRX He’s not a Tainted Sea Turdal he’s a SCARDY KAT.
-
$BCRX Ha Joe Putin just landed in Bangor Maine and he wants to meet with you …tell him I’m having lunch with Hunter at 2:00 then I’m heading to the bunker see what his plans are for tomorrow.
-
-
$BCRX Down the Rabbit hole ?Not BuggZ
-
$BCRX @Bio99 your not saying someone is thanking their lucky stars for all of this distraction…come on man
-
$BCRX Get off the lot Harrington your a f…ing looser
-
-
Should have diversified some of my funds here instead of all in on AUPH
Congrats BCRX investors -
$BCRX What was the largest intra day gain for BCRX over the past 3 yrs.?
-
-
$BCRX Man that was like going through a six hour blow job and no orgasm and I’m 78 yrs old damn
-
$BCRX Who’s gona do it keep buying you could be the one
-
$BCRX I kick it I kicked it a couple of times this morning someone else try
-
BioCryst Pharmaceuticals rallies on Quebec reimbursement for Orladeyo angioedema treatment
proactiveinvestors.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2023 Earnings Call Transcript
seekingalpha.com • -
BioCryst to Report Second Quarter 2023 Financial Results on August 3
globenewswire.com • -
BioCryst to Present at Upcoming Investor Conference
globenewswire.com • -
BioCryst to Report First Quarter 2023 Financial Results on May 3
globenewswire.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst: Good Candidate For Buyout, But Not For Anything Else
seekingalpha.com • -
BioCryst Is Not Currently Uncovering The Full Value Of ORLADEYO
seekingalpha.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call Transcript
seekingalpha.com • -
BioCryst to Report Fourth Quarter 2022 Financial Results on February 21
globenewswire.com • -
Pharmaceutical Stock Sinks on Sales Forecast
schaeffersresearch.com • -
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
BioCryst Pharmaceuticals: More Aggressive Growth For Orladeyo
seekingalpha.com • -
BCRX Stock Sinks as BioCryst Discontinues Drug Development
investorplace.com • -
BioCryst to discontinue development of drug
marketwatch.com • -
BioCryst to Present at JMP Securities Hematology & Oncology Summit
globenewswire.com • -
3 Biotechnology stocks under 10 dollars to buy now
thedogofwallstreet.com • -
BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
BioCryst to Report Third Quarter 2022 Financial Results on November 1
globenewswire.com • -
3 Biotech Stocks to Buy Now for Extraordinary Gains
investorplace.com • -
Options Bulls Blast Phama Stock on Lifted Clinical Hold
schaeffersresearch.com • -
3 Fast-Growing Stocks to Buy Now
fool.com • -
BioCryst to Report Second Quarter 2022 Financial Results on August 4
globenewswire.com • -
BioCryst to Present at Upcoming Investor Conference
globenewswire.com • -
BioCryst: A Prudent Diversification
seekingalpha.com • -
7 Cheap Biotech Stocks to Buy Now
investorplace.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst to Report First Quarter 2022 Financial Results on May 5
globenewswire.com • -
Why BioCryst Pharmaceuticals Stock Is Falling
benzinga.com • -
BioCryst to Present at Upcoming Investor Conference
globenewswire.com • -
Why BioCryst Pharmaceuticals Stock Is Plunging Today
benzinga.com • -
BioCryst Provides Tremendous Option Value
seekingalpha.com • -
BioCryst: Great Execution, Impressive Pipeline, Long Cash Runway
seekingalpha.com • -
7 Top Growth Stocks to Buy as We Step Into November
investorplace.com • -
BioCryst to Report Third Quarter 2021 Financial Results on November 3
globenewswire.com • -
7 Best Growth Stocks to Buy and Hold for the Next 10 Years
investorplace.com • -
2 Super-Charged Growth Stocks to Buy Now
fool.com • -
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com • -
NICE Recommends BioCryst's Hereditary Angioedema Med
benzinga.com • -
What Wall Street Still Has Wrong. BioCryst To Become Next Rare Disease Giant
seekingalpha.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com • -
BioCryst Appoints Dr. Steven Galson to Board of Directors
globenewswire.com • -
BioCryst Stock Jumps After Pulling Out $200M Equity Raise
benzinga.com • -
BioCryst Withdraws Public Offering
globenewswire.com • -
BioCryst Pharma Stock Heads Higher Thursday: Here's Why
benzinga.com • -
3 Biotech Stocks That Could Rocket Higher
fool.com • -
BioCryst to Report Second Quarter 2021 Financial Results on August 5
globenewswire.com • -
BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
seekingalpha.com •